Baohui Han

机构：Shanghai Jiao Tong University, Shanghai Chest Hospital, Shanghai Pulmonary Hospital

发表论文 24 篇 · 总被引 499 次 · h-index 8

代表论文

• Chinese experts’ consensus on the Internet of Things-aided diagnosis and treatment of coronavirus disease 2019 (COVID-19) (2020 · Clinical eHealth · 被引 225)
• First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study (2023 · The Lancet · 被引 164)
• Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial (2024 · The Lancet Respiratory Medicine · 被引 21)
• Neoadjuvant Immunotherapy for Patients With Non–Small Cell Lung Cancer—Is a New Era Coming? (2023 · JAMA Oncology · 被引 21)
• Safety of polyethylene glycol recombinant human granulocyte colony-stimulating factor in treating non-small cell lung cancer patients at I b stage (2013 · Asian Pacific Journal of Tropical Medicine · 被引 10)
• Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: a prospective, single-arm, two-stage study (2024 · BMC Cancer · 被引 8)